Free Trial

Theratechnologies (THTX) SEC Filings & 10K Form

Theratechnologies logo
$2.52 -0.05 (-1.95%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.52 0.00 (0.00%)
As of 04/17/2025 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Theratechnologies SEC Filings

DateFilerForm TypeView
04/16/2025
9:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
10:47 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
6:30 PM
Soleus Capital Master Fund, L.P. (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13D/A
04/09/2025
8:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
8:22 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2025
10:13 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
12:09 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
11:52 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
7:32 AM
Theratechnologies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2025
7:30 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2025
3:37 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
2:21 PM
MORGAN STANLEY (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:12 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
9:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:24 AM
HIRSCHMAN ORIN (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
01/10/2025
6:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
10:58 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
5:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
1:35 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
9:43 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
10:44 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
7:53 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:20 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
10:41 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
10/10/2024
7:36 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
7:31 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
10:05 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
9:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2024
7:35 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2024
7:35 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2024
4:26 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:THTX) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners